These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 796500)

  • 1. [Cancer immunotherapy and its fundamental basis (author's transl)].
    Yamamura Y
    Nihon Hifuka Gakkai Zasshi; 1976 Sep; 86(10):584-91. PubMed ID: 796500
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
    Azuma I; Yamamura Y
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunotherapy of cancer with BCG].
    Yamamura Y; Azuma I
    Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].
    Ogura T
    Kekkaku; 1980 Aug; 55(8):359-63. PubMed ID: 6999203
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
    Peter HH; Deutschmann EM; Schultheis W; Deicher H
    Dev Biol Stand; 1977 Apr 13-15; 38():537-40. PubMed ID: 344106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant melanoma and immunotherapy.
    Br Med J; 1976 Oct; 2(6040):831-2. PubMed ID: 791438
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
    Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: BCG in cancer.
    Br Med J; 1976 Jun; 1(6024):1487. PubMed ID: 776334
    [No Abstract]   [Full Text] [Related]  

  • 9. The methanol extract residue (MER) of bacillus calmette-guerin in cancer immunotherapy.
    Domenick NP
    Nurs Clin North Am; 1978 Jun; 13(2):369-80. PubMed ID: 353752
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy in malignant melanomaa.
    Homes EC; Morton DL; Eilber FR; Golub SE; Sulit HL
    Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of cancer in man.
    Carter SK
    Am Sci; 1976; 64(4):418-23. PubMed ID: 786091
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.
    Wile AG; Sparks FC; Morton DL
    Cancer Res; 1977 Jul; 37(7 Pt 1):2251-6. PubMed ID: 324610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of immunotherapy of malignant tumors].
    Flad HD; Betzler M; Herfarth C
    Chirurg; 1979 Jan; 50(1):11-5. PubMed ID: 367730
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cancer immunotherapy in dermatological view (author's transl)].
    Lübbe D; Gstöttner R
    Arch Geschwulstforsch; 1980; 50(2):182-5. PubMed ID: 7436703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral bacille Calmette Guérin immunostimulation in malignant melanoma.
    MacGregor AB; Falk RE; Landi S; Ambus U; Langer B
    Surg Gynecol Obstet; 1975 Nov; 141(5):747-54. PubMed ID: 1105837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunology of brain tumors (author's transl)].
    Takakura K
    No To Shinkei; 1976 Jun; 28(6):525-37. PubMed ID: 194610
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adjuvant immunotherapy with BCG for malignant brain tumors (author's transl)].
    Miki Y; Sano K; Takakura K; Mizutani H
    Neurol Med Chir (Tokyo); 1976 Jul; 16(4 pt 2):357-64. PubMed ID: 62316
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)].
    Wätzig V; Knopf B
    Arch Geschwulstforsch; 1979; 49(2):140-5. PubMed ID: 475550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapy with BCG and mycobacterial fractions and its use in bronchogenic carcinoma (author's transl)].
    Brehmer W; Huckauf H; Ribi E
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():358-65. PubMed ID: 461310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.